Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer Patients

Lung Cancer Clinical Trial

Official title:

Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03881046
• Other study ID #: GO 18/737-08
• Status: Completed
• Start date: February 1, 2019
• Est. completion date: June 17, 2020

Study information

• Verified date: January 2023
• Source: Hacettepe University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The aim of our study was to compare the daily living activities with a performance-based protocol in lung cancer patients and healthy controls.

Description:

Lung cancer is the abnormal proliferation of cells in the lung tissue and a mass in the lung. The primary symptoms of this health problem include cough, dyspnea, chest pain, hemoptysis and sputum. In addition to these symptoms, muscle strength, respiratory function and effort level are decreased.

Inadequate daily living activities in cancer patients are expressed.But studies evaluating the activities of daily living in patients with lung cancer are inadequate and patients are evaluated only using scales. For the measurement of functional status in daily living activities, these scales provide important information about the detection of symptoms and the progression of the disease. However, it is very difficult to determine the limitation of perceived difficulty in daily living activities with these scales. In addition, since these scales are a method of measurement, the objectivity is open to discussion. It is thought that a performance-based protocol will facilitate the detection of limitations and provide more objective findings. We think that the Londrina protocol fully reflects the activities of daily living and thus will give us an objective measurement.

This study will show us the problem and its cause in daily life activities in patients with lung cancer.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 44
• Est. completion date: June 17, 2020
• Est. primary completion date: January 17, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 30 Years to 80 Years

Eligibility

Inclusion Criteria:

• To have a diagnosis of lung cancer

• Complete chemotherapy

• Complete radiotherapy

• Coopere,

• Accepts participation in the study will be included in the study

Exclusion Criteria:

• Neurological, cognitive or orthopedic diseases that affect the measurements

• Acute infection

• Individuals with other chronic diseases that may affect their walking will not be included in the study

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

Locations

Country	Name	City	State
Turkey	Hamide Sahin	Ankara

Sponsors (1)

Lead Sponsor	Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Activities Of Daily Living	Daily Living Activities will be evaluated using the Londrina Protocol.The protocol consists of 5 stations. Stations are including organizing books on the table, 18 meters walking by carrying 10% of body weight symmetrically, arranging books by putting them on shelves, hanging the laundry in the laundry basket and walking 18 meters. Individual will do these activities at his own pace and the time will be recorded at the end.	1st day
Secondary	Life Quality	Quality of life will be measured using Core Quality of Life Questionnaire (EORTC QLQ-C30) The questionnaire consists of 30 questions and provides information on quality of life and symptoms.	1st Day
Secondary	Peripheral Muscle Strength	Muscle strength will be evaluated by force measuring dynamometer device 3 times. M.Quadriceps Femoris, shoulder abduction, shoulder flexion, elbow flexion, elbow extension and hand grip strength of all cases will be measured.	1st Day
Secondary	Dyspnoea	Dyspnoea will be evaluated using the Medical Research Council Dyspnoea Scale. The Medical Research Council Dyspnoea Scale has a score of 0-4. In this scoring system 0 indicates that there is no dyspnoea, whereas 4 indicates that the dyspnoea is too high.	1st Day
Secondary	Respiratory Functions	Respiratory functions will be measured by spirometric measurement. This measurement will give us FEV1 FVC FEV1 / FVC values.	1st Day
Secondary	Exercise Capacity	6 Minute walk test will be used.In the test, the person will be asked to walk as fast as possible in a 30-meter corridor and the walking distance will be recorded in 6 minutes.	1st Day